BMY has been in the news 450% more than usual
Dec 03, 2025, 9:31 PM
5.81%
What does BMY do
Bristol Myers Squibb Co., based in Princeton, NJ, employs 34,100 staff and develops biopharmaceuticals across various therapeutic classes, including oncology and immunology. Key products include Eliquis and Opdivo, with a strong pipeline featuring Krazati and KarXT.
BMY has been in the news recently: Bristol Myers Squibb Company announced plans to enroll more patients in the ADEPT-2 Phase 3 study, which led to an increase in the company's share price. This decision was made public on Wednesday.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.